Topical rapamycin inhibits tuberous sclerosis tumor growth in a nude mouse model
Skin manifestations of Tuberous Sclerosis Complex (TSC) cause significant morbidity. The molecular mechanism underlying TSC is understood and there is evidence that systemic treatment with rapamycin or other m...